KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $2.30 $3.29 Friday, 26th Apr 2024 ABUS stock ended at $2.73. This is 0.368% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 2.21% from a day low at $2.71 to a day high of $2.77.
90 days $2.27 $3.29
52 weeks $1.69 $3.29

Historical Arbutus Biopharma Corporation prices

Date Open High Low Close Volume
Aug 20, 2020 $3.45 $3.46 $3.31 $3.34 1 693 491
Aug 19, 2020 $3.40 $3.57 $3.37 $3.45 1 981 794
Aug 18, 2020 $3.47 $3.50 $3.37 $3.45 1 733 211
Aug 17, 2020 $3.47 $3.58 $3.39 $3.48 2 158 876
Aug 14, 2020 $3.35 $3.51 $3.31 $3.47 2 721 739
Aug 13, 2020 $3.45 $3.47 $3.26 $3.43 4 614 758
Aug 12, 2020 $3.93 $3.96 $3.50 $3.56 14 076 221
Aug 11, 2020 $3.66 $3.97 $3.34 $3.44 11 367 320
Aug 10, 2020 $3.72 $3.76 $3.61 $3.66 2 464 962
Aug 07, 2020 $3.91 $4.04 $3.43 $3.80 11 228 100
Aug 06, 2020 $4.44 $4.89 $4.25 $4.37 8 646 290
Aug 05, 2020 $3.76 $4.42 $3.76 $4.18 8 133 065
Aug 04, 2020 $3.82 $3.86 $3.66 $3.75 2 896 812
Aug 03, 2020 $3.86 $4.01 $3.79 $3.83 3 356 913
Jul 31, 2020 $4.31 $4.37 $3.80 $3.81 5 114 088
Jul 30, 2020 $3.93 $4.50 $3.81 $4.30 8 586 722
Jul 29, 2020 $3.88 $4.23 $3.71 $4.04 9 297 658
Jul 28, 2020 $4.04 $4.30 $3.92 $4.02 13 043 387
Jul 27, 2020 $5.44 $5.72 $4.35 $4.47 31 859 090
Jul 24, 2020 $7.98 $9.02 $4.77 $4.96 218 467 075
Jul 23, 2020 $2.91 $6.48 $2.66 $6.20 95 532 924
Jul 22, 2020 $3.02 $3.06 $2.75 $2.82 1 685 300
Jul 21, 2020 $2.89 $3.47 $2.36 $2.87 9 281 700
Jul 20, 2020 $2.33 $3.22 $2.21 $2.97 22 599 600
Jul 17, 2020 $2.09 $2.58 $2.04 $2.40 3 447 100
Click to get the best stock tips daily for free!

About Arbutus Biopharma Corporation

Arbutus Biopharma Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical trial targeted to hepatocytes that inhibits viral replication and reduces various HBV antigens using novel ... ABUS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT